Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Juvenile dermatomyositis

A R Halbert1

  • 1Department of Dermatology, Princess Margaret Hospital for Children, Subiaco, Western Australia.

The Australasian Journal of Dermatology
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Juvenile dermatomyositis (JDMS) is a chronic inflammatory disease causing muscle weakness and rash. Early treatment with immunosuppressants and IVIG can reduce JDMS complications and improve outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics and outcome of t(8;21)-positive childhood acute myeloid leukemia: a single institution's experience.

Leukemia·2002
Same author

Cytogenetic analysis of a scapular chondromyxoid fibroma.

Cancer genetics and cytogenetics·1998
Same author

The practical management of atopic dermatitis in children.

Pediatric annals·1996
Same author

Atopic dermatitis: is it an allergic disease?

Journal of the American Academy of Dermatology·1995
Same author

Allopurinol for Old World cutaneous leishmaniasis.

Pediatric dermatology·1995
Same author

Discoid lupus erythematosus.

The Australasian journal of dermatology·1995

Area of Science:

  • Rheumatology
  • Pediatrics
  • Immunology

Background:

  • Juvenile dermatomyositis (JDMS) is a rare autoimmune disease.
  • It presents with characteristic muscle weakness and a heliotrope rash.
  • Underlying vasculopathy contributes to disease manifestations.

Purpose of the Study:

  • To summarize the key aspects of Juvenile Dermatomyositis.
  • To highlight the long-term complications associated with JDMS.
  • To emphasize the importance of early and aggressive treatment strategies.

Main Methods:

  • Literature review of JDMS pathophysiology and treatment.
  • Analysis of long-term outcomes and complications.
  • Evaluation of current therapeutic approaches.

Related Experiment Videos

Main Results:

  • JDMS can lead to significant long-term complications.
  • These include subcutaneous and muscular calcification and contractures.
  • A secondary connective tissue disease may develop in some patients.

Conclusions:

  • Early and aggressive treatment is crucial for managing JDMS.
  • Systemic immunosuppressants and intravenous immunoglobulin (IVIG) are key therapeutic agents.
  • Timely intervention reduces mortality and morbidity in juvenile dermatomyositis patients.